Martingale Asset Management’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
Martingale Asset Management's ANGO Position: Q2 2022 in Review
Martingale Asset Management sold out of AngioDynamics (ANGO) in Q2 2022, closing a stake of 20,914 shares — an estimated $451K sold.
Martingale Asset Management first reported a position in ANGO in Q1 2016 and held it in 23 quarters. The position peaked at $4.28M in Q1 2019. 134 funds tracked by Wall St. Rank hold ANGO as of Q2 2022.
- Martingale Asset Management reported no remaining AngioDynamics position as of Q2 2022 after selling out during the quarter.
- Martingale Asset Management sold 20,914 AngioDynamics shares in Q2 2022, an estimated $451K.
- Martingale Asset Management first reported a position in AngioDynamics in Q1 2016 and held it in 23 quarters.
- Martingale Asset Management's AngioDynamics position peaked at $4.28M in Q1 2019.
- 134 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2022.
Based on Martingale Asset Management's 13F filing for Q2 2022, filed 11 Aug 2022.